Ozempic & GLP-1 litigation — safety & in… | DrugsMonitor.com

Clinical summary and reported injury patterns for Ozempic & GLP-1 litigation. Links to FDA recalls and litigation overview. Not medical advice.

semaglutide, tirzepatide, Wegovy, Mounjaro, Rybelsus, gastroparesis, intestinal obstruction

Clinical context

Ang mga agonist ng receptor ng GLP-1 (semaglutide, liraglutide, tirzepatide) ay sinasabing nagdudulot ng matinding gastroparesis, bara, sakit sa gallbladder, at pancreatitis sa ilang mga gumagamit.

Litigation context

MDL No. 3094 sa Silangang Distrito ng Pennsylvania; pagtuklas at bellwether planning na aktibo sa 2026.